Downregulation of other cancer-promoting molecules such as HDAC6, required for efficient oncogenic tumorigenesis [188], and NCoA1, whose overexpression increases the number of circulating cancer cells and the metastasis [189], may overwhelm PTEN’s efficacy in this case. The gene discussed is HDAC6; the disease is cancer.